Lawsuits have been filed nationwide alleging that Johnson & Johnson’s Risperdal can cause gynecomastia, the development of breasts, in young boys. Risperdal, an anti-psychotic prescribed to patients ages 10 and up, is used to treat psychological disorders such as schizophrenia and bipolar disorder, as well as certain symptoms of autism in children over the age of five. In addition to claiming that the drug led to the development of gynecomastia in young boys, the suits further allege Johnson & Johnson illegally marketed Risperdal for off-label uses in both adults and minors, with some patients younger than 10-years-old alleged to have developed breast tissue.
Gynecomastia (the abnormal growth of breast tissue) is the result of increased levels of the hormone prolactin, which is usually found only in breastfeeding women. It is believed that Risperdal can increase levels of prolactin in users and cause young boys, and even adult men, to develop breasts and begin producing milk. In one case, a four-year-old allegedly began lactating as a result of taking Risperdal and needed to undergo a mastectomy—the only known treatment for gynecomastia—to correct the problem.
If you or a loved one developed male breast tissue after taking Risperdal, you may be able to file a lawsuit against Johnson & Johnson and recover compensation for your injuries. Fill out the form on this page to receive a free online evaluation and more information on your potential legal rights.